- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04412759
PORCINE XENOGRAFT OR MICROBIAL CELLULOSE IN THE TREATMENT OF PARTIAL THICKNESS BURNS
May 29, 2020 updated by: Folke Sjoberg, University Hospital, Linkoeping
PORCINE XENOGRAFT OR MICROBIAL CELLULOSE IN THE TREATMENT OF PARTIAL THICKNESS BURNS - A RANDOMISED CLINICAL TRIAL
The purpose of this study was to compare two wound dressing products for partial thickness burns in adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
After being informed about the study, all patients that had given written informed consent underwent screening.
If eligible study participants were randomized to be treated wih either the standard dressing of care; pigskin or a microbial cellulose.
Dressing were applied within 72 hours after burn injury.
Evaluation was done in an open manner due to the specific characteristics of the dressings.
Study particpants were followed weekly until complete wound closure and after that evaluated at 6 and 12 months after injruy for burn scar outcome.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Linköping, Sweden, 58185
- The Burn Centre at Linköping University Hospital,
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Study participants admitted within 72 hours of injury
- partial-thickness burns requiring a temporary skin cover
- written informed consent
Exclusion Criteria:
- severe coexisting cutaneous trauma
- chronic or current skin disease,
- severe cognitive dysfunction or psychiatric disorder
- pregnant or breast feeding women were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Porcine xenograft
porcine xenograft derived from dermal porcine skin.
Standard of care treatement for partila thickness burn at the specfic centre
|
|
|
EXPERIMENTAL: Microbial cellulose
Novel dressing consisting of a biopolymer spun by the bacteria Acetobacter xylinum (later removed).
|
polymer dressing synthesized in abundance with Acetobacter Xylinum
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to complete healing of the burn
Time Frame: Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
|
Healing time was calculated from the date of injury to the date when the wound bed was assessed as completely (100 %) re-epithelialized, with no need for further dressing changes other than protection against shearing according to the treating physician.
|
Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Burn wound infection
Time Frame: Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
|
Wound infections were diagnosed (by the burn surgeon) if they fulfilled at least two of the following criteria: (based on the American Burn Association definition of burn wound infection)
|
Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
|
|
Burn wound pain
Time Frame: Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
|
The patients were asked to estimate the burn wound pain at rest, during activity, and during dressing changes using a numerical rating scale (NRS) where 0 indicated no pain and 10 the worst pain ever imaginable.
|
Evaluated at each visit (1-3 times per week) from admission until complete healing, up to 6 months
|
|
Duration of hospital stay (LOS)
Time Frame: From admission until discharge, up to 6 months
|
All patients hospitalized for their burns were monitored by the study nurse and the day of discharge was noted in the CRF.
Any readmission after initial discharge was also noted and included in the total length of stay.
|
From admission until discharge, up to 6 months
|
|
Burn scar outcome
Time Frame: Evaluated at six and 12 months after injury
|
Burn scar outcome was evaluated using the Patient Observer Scar Assessment Scale (POSAS).
The scale includes two separate subscales, The Observer Sscale, used by an experienced burn occupational therapist and the Patient Sscale, used by the study participants.
|
Evaluated at six and 12 months after injury
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2016
Primary Completion (ACTUAL)
November 1, 2018
Study Completion (ACTUAL)
November 1, 2019
Study Registration Dates
First Submitted
May 29, 2020
First Submitted That Met QC Criteria
May 29, 2020
First Posted (ACTUAL)
June 2, 2020
Study Record Updates
Last Update Posted (ACTUAL)
June 2, 2020
Last Update Submitted That Met QC Criteria
May 29, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MC-2015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burn Scar
-
Riphah International UniversityRecruiting
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | ScarUnited States
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | Scar | Skin Graft ScarUnited States
-
Bispebjerg HospitalUnknownBurn Scar PatientsDenmark
-
University of PittsburghUnited States Department of DefenseTerminatedBurn Scar | Restrictive Scar Contracture | Restrictive Hypertrophic Scar | Burn Scar ContracturesUnited States
-
Centre hospitalier de l'Université de Montréal...Completed
-
Cairo UniversityCompletedBurns | Hypertrophic Scar | Burn Scar (Post-burn)Egypt
-
MTI UniversityCompleted
-
Kaiyang Lv, MD-PhDZimmer Medical Devices (Shanghai) Co., Ltd.RecruitingBurn Scar | Cryotherapy Effect | Scar; Previous Cesarean SectionChina
-
Centre hospitalier de l'Université de Montréal...Completed
Clinical Trials on microbial cellulose
-
University of AlbertaThe Weston A. Price FoundationCompleted
-
UMC UtrechtZimmer BiometEnrolling by invitationPeriprosthetic Joint Infection | PJINetherlands, Spain, Germany, Portugal, Slovenia, Switzerland
-
VA Office of Research and DevelopmentCompleted
-
Rambam Health Care CampusUnknownMicrobiology, Maxilla
-
University GhentCompletedHeavy, Bad Body Odour From Armpit | Heavy, Bad Body Odour From FootBelgium
-
Case Western Reserve UniversityRecruitingPeriodontal Diseases | Microbial Colonization | Edentulous Mouth | Periodontitis, AdultUnited States
-
University GhentUniversity Hospital, GhentCompleted
-
Puerta de Hierro University HospitalNot yet recruitingRecurrence | Cholangitis Acute
-
Hospital Clinic of BarcelonaISCIIIRecruitingBronchiectasis | Microbial Colonization | Pseudomonas Aeruginosa | BiofilmSpain
-
F.D. Roosevelt Teaching Hospital with Policlinic...Recruiting